Founder/CEO and Clinical President of Digital Health Company Convicted in $100M Adderall Distribution Scheme

Summary

U.S. Department of Justice, Office of Public Affairs press release dated Wednesday, November 19, 2025, Press Release Number 25-1090, headed Founder/CEO and Clinical President of Digital Health Company Convicted in $100M Adderall Distribution and Health Care Fraud Scheme. DOJ states that a federal jury in San Francisco convicted Ruthia He, founder and CEO of Done, and David Brody, its clinical president, of conspiracy to distribute controlled substances, distribution of controlled substances and conspiracy to commit health care fraud, and that He was also convicted of conspiracy to obstruct justice. DOJ alleges evidence showed over $40 million spent on advertisements and Medicare, Medicaid and commercial insurers paying in excess of approximately $14 million. Sentencings are set for Feb. 25, 2026.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

PRESS RELEASE

A federal jury in San Francisco yesterday convicted Ruthia He, the founder and CEO of Done, a California-based digital health company, and David Brody, its clinical president, for their roles in a years-long scheme to illegally distribute Adderall over the internet and conspire to commit health care fraud in connection with the submission of false and fraudulent claims for reimbursement for Adderall and other stimulants. Ruthia He was also convicted of conspiring to obstruct justice.

According to court documents and evidence presented at trial, He and Brody conspired with others to build a billion-dollar technology company and raise money from investors by providing easy access to over 40 million pills of Adderall and other stimulants in exchange for payment of a monthly subscription fee.

He and Done spent over $40 million on deceptive advertisements on social media networks that sought to convince Americans challenged by a lack of structure during the COVID-19 pandemic that they were suffering from ADHD. Defendants also paid for targeted keyword search advertisements for drug seekers who wanted to obtain Adderall without a legal prescription.

In order to ensure that members continued paying monthly subscription fees, He, Brody, and others conspired to defraud insurers so that Done members would be able to use insurance to pay for Adderall dispensed at pharmacies. As a result, Medicare, Medicaid, and the commercial insurers paid in excess of approximately $14 million.

To obstruct the government's investigation, He moved operations to China, used encrypted messaging apps with disappearing messages, deleted incriminatory documents, transferred over $1 million to a Chinese shell company named Make Believe Asia, conducted internet searches for countries that did not have extradition, and was stopped by law enforcement leaving the country.

He and Brody were both convicted of one count of conspiracy to distribute controlled substances, four counts of distribution of controlled substances, and one count of conspiracy to commit health care fraud. He was also convicted of one count of conspiracy to obstruct justice. Sentencings are set for Feb. 25, 2026.

The DEA, HHS-OIG, HSI, and IRS Criminal Investigation are investigating the case. Acting Health Care Fraud Unit Chief Jacob Foster, Assistant Chief Emily Gurskis, and Trial Attorney Arun Bodapati of the Criminal Division's Fraud Section and Assistant U.S. Attorney Kristina Green, for the Northern District of California are prosecuting the case.

File and source

File

DOJ_2025-11-19_done-global-ruthia-he-100m-adderall-conviction.md.txt

Size

2,552 bytes

SHA-256

245e85f34a63e44efda75342d52de2951889396d1333d926c6b59d74c6101918

Our copy

DOJ_2025-11-19_done-global-ruthia-he-100m-adderall-conviction.md.txt

Original

www.justice.gov